EA201491818A1 - Способ получения оптически чистых и необязательно замещенных производных 2-(1-гидроксиалкил)хромен-4-она и их применение при получении лекарственных препаратов - Google Patents
Способ получения оптически чистых и необязательно замещенных производных 2-(1-гидроксиалкил)хромен-4-она и их применение при получении лекарственных препаратовInfo
- Publication number
- EA201491818A1 EA201491818A1 EA201491818A EA201491818A EA201491818A1 EA 201491818 A1 EA201491818 A1 EA 201491818A1 EA 201491818 A EA201491818 A EA 201491818A EA 201491818 A EA201491818 A EA 201491818A EA 201491818 A1 EA201491818 A1 EA 201491818A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- chromen
- hydroxialkyl
- optically pure
- substituted derivatives
- optional substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
- C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
Abstract
Настоящее изобретение относится к соединениям, которые пригодны для применения в качестве фармацевтических промежуточных продуктов, к способам получения промежуточных продуктов, промежуточным продуктам, применяемым в этих способах, и к применению промежуточных продуктов в получении лекарственных средств. В частности, настоящее изобретение раскрывает энантиомерно чистые необязательно замещенные производные 2-(1-гидроксиалкил)хромен-4-она, представленные формулой (IA) и (IB), способ для получения производных спирта и их применение в получении лекарственных средств.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1737CH2012 | 2012-05-04 | ||
| US201261671956P | 2012-07-16 | 2012-07-16 | |
| PCT/IB2013/053544 WO2013164801A1 (en) | 2012-05-04 | 2013-05-03 | Process for preparation of optically pure and optionally substituted 2- (1 -hydroxy- alkyl) - chromen - 4 - one derivatives and their use in preparing pharmaceuticals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201491818A1 true EA201491818A1 (ru) | 2015-04-30 |
| EA032812B1 EA032812B1 (ru) | 2019-07-31 |
Family
ID=54193684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201491818A EA032812B1 (ru) | 2012-05-04 | 2013-05-03 | Способ получения оптически чистых и необязательно замещенных производных 2-(1-гидроксиалкил)хромен-4-она и их применение при получении лекарственных препаратов |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US9309216B2 (ru) |
| EP (1) | EP2844647B1 (ru) |
| JP (2) | JP6290186B2 (ru) |
| KR (1) | KR102073181B1 (ru) |
| CN (2) | CN108084138A (ru) |
| AP (1) | AP3547A (ru) |
| AU (1) | AU2013255469B2 (ru) |
| BR (1) | BR112014027470A2 (ru) |
| CA (1) | CA2871000C (ru) |
| CL (1) | CL2014002986A1 (ru) |
| CO (1) | CO7141413A2 (ru) |
| CY (1) | CY1123456T1 (ru) |
| EA (1) | EA032812B1 (ru) |
| HK (1) | HK1203964A1 (ru) |
| IL (1) | IL235181A (ru) |
| MX (1) | MX365250B (ru) |
| MY (1) | MY171207A (ru) |
| NZ (1) | NZ701198A (ru) |
| PH (1) | PH12014502453B1 (ru) |
| PL (1) | PL2844647T3 (ru) |
| RS (1) | RS61035B1 (ru) |
| SG (1) | SG11201407184PA (ru) |
| SI (1) | SI2844647T1 (ru) |
| WO (1) | WO2013164801A1 (ru) |
| ZA (1) | ZA201407769B (ru) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5889795B2 (ja) | 2009-11-05 | 2016-03-22 | ライゼン・ファーマシューティカルズ・エスアー | 新規キナーゼモジュレーター |
| BR112014027470A2 (pt) * | 2012-05-04 | 2017-06-27 | Rhizen Pharmaceuticals S A | novo processo para preparação de derivados 2-(1-hidroxi-alquilo)-cromen-4-ona oticamente puros e opcionalmente substituídos e seu uso na preparação de produtos farmacêuticos. |
| US10130635B2 (en) | 2012-05-04 | 2018-11-20 | Rhizen Pharmaceuticals Sa | Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals |
| SG11201509992RA (en) | 2013-06-07 | 2016-01-28 | Rhizen Pharmaceuticals Sa | Dual selective pi3 delta and gamma kinase inhibitors |
| SG11201610745XA (en) | 2014-06-27 | 2017-01-27 | Rhizen Pharmaceuticals Sa | Substituted chromene derivatives as selective dual inhibitors of pi3 delta and gamma protein kinases |
| US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
| JP2018521044A (ja) * | 2015-07-23 | 2018-08-02 | ファーマケア，インク． | リシルオキシダーゼ様２阻害剤とその使用 |
| US10588900B2 (en) | 2016-02-09 | 2020-03-17 | Pharmakea, Inc. | Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof |
| WO2017214269A1 (en) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| WO2023130334A1 (zh) * | 2022-01-07 | 2023-07-13 | 同润生物医药(上海)有限公司 | 一种色烯-4-酮化合物及其中间体的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62201882A (ja) * | 1985-11-18 | 1987-09-05 | Yamanouchi Pharmaceut Co Ltd | イソフラボン誘導体 |
| PE20060426A1 (es) * | 2004-06-02 | 2006-06-28 | Schering Corp | DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa |
| JP5889795B2 (ja) | 2009-11-05 | 2016-03-22 | ライゼン・ファーマシューティカルズ・エスアー | 新規キナーゼモジュレーター |
| PT2705029T (pt) * | 2011-05-04 | 2019-02-01 | Rhizen Pharmaceuticals S A | Novos compostos como moduladores de proteína quinases |
| BR112014027470A2 (pt) * | 2012-05-04 | 2017-06-27 | Rhizen Pharmaceuticals S A | novo processo para preparação de derivados 2-(1-hidroxi-alquilo)-cromen-4-ona oticamente puros e opcionalmente substituídos e seu uso na preparação de produtos farmacêuticos. |
| HUE034591T2 (en) * | 2012-07-04 | 2018-02-28 | Rhizen Pharmaceuticals S A | Selective PI3K delta inhibitors |
-
2013
- 2013-05-03 BR BR112014027470A patent/BR112014027470A2/pt not_active Application Discontinuation
- 2013-05-03 CA CA2871000A patent/CA2871000C/en not_active Expired - Fee Related
- 2013-05-03 AP AP2014008087A patent/AP3547A/xx active
- 2013-05-03 JP JP2015509560A patent/JP6290186B2/ja not_active Expired - Fee Related
- 2013-05-03 KR KR1020147034065A patent/KR102073181B1/ko active IP Right Grant
- 2013-05-03 CN CN201810028555.5A patent/CN108084138A/zh active Pending
- 2013-05-03 SG SG11201407184PA patent/SG11201407184PA/en unknown
- 2013-05-03 CN CN201380023361.1A patent/CN104507922B/zh not_active Expired - Fee Related
- 2013-05-03 WO PCT/IB2013/053544 patent/WO2013164801A1/en active Application Filing
- 2013-05-03 US US14/398,902 patent/US9309216B2/en not_active Expired - Fee Related
- 2013-05-03 PL PL13729095T patent/PL2844647T3/pl unknown
- 2013-05-03 EP EP13729095.3A patent/EP2844647B1/en active Active
- 2013-05-03 NZ NZ701198A patent/NZ701198A/en not_active IP Right Cessation
- 2013-05-03 MY MYPI2014003098A patent/MY171207A/en unknown
- 2013-05-03 MX MX2014013426A patent/MX365250B/es active IP Right Grant
- 2013-05-03 SI SI201331803T patent/SI2844647T1/sl unknown
- 2013-05-03 RS RS20201267A patent/RS61035B1/sr unknown
- 2013-05-03 EA EA201491818A patent/EA032812B1/ru unknown
- 2013-05-03 AU AU2013255469A patent/AU2013255469B2/en not_active Ceased
-
2014
- 2014-10-19 IL IL235181A patent/IL235181A/en active IP Right Grant
- 2014-10-24 ZA ZA2014/07769A patent/ZA201407769B/en unknown
- 2014-11-03 PH PH12014502453A patent/PH12014502453B1/en unknown
- 2014-11-04 CL CL2014002986A patent/CL2014002986A1/es unknown
- 2014-12-03 CO CO14266920A patent/CO7141413A2/es unknown
-
2015
- 2015-05-19 HK HK15104774.7A patent/HK1203964A1/xx unknown
-
2017
- 2017-12-14 JP JP2017239643A patent/JP2018039849A/ja active Pending
-
2020
- 2020-10-15 CY CY20201100974T patent/CY1123456T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201491818A1 (ru) | Способ получения оптически чистых и необязательно замещенных производных 2-(1-гидроксиалкил)хромен-4-она и их применение при получении лекарственных препаратов | |
| CY1116987T1 (el) | Συμπυκνωμενα ιμιδαζολυλιμιδαζολια ως αντιϊικες ενωσεις | |
| CY1118379T1 (el) | Αναστολεις ιου ηπατιτιδας c | |
| EA201690520A1 (ru) | Способ получения замещенных 5-фтор-1h-пиразолопиридинов | |
| CR20150370A (es) | Compuestos antivirales | |
| EA201490546A1 (ru) | Замещенные аннелированные пиримидины и их применение | |
| EA201401292A2 (ru) | Новые тиенопиримидиновые производные, способ их получения и фармацевтические композиции, содержащие их | |
| EA201690246A1 (ru) | Ингибиторы аутотаксинов, содержащие ядро гетероароматическое кольцо-бензил-амидный цикл | |
| EA201592144A1 (ru) | Производное фенола, способ его получения и его применение в медицине | |
| CL2014000245A1 (es) | Compuestos derivados de heterociclos nitrogenados, inhibidores de replicacion de los virus de influenza; metodo de preparacion; composicionn farmaceutica; metodo para inhibir la replicacion del virus de la influenza en una muestra biológica o un paciente. | |
| EA201591166A1 (ru) | Ингибиторы аутотаксина | |
| UY33370A (es) | Composiciones farmacéuticas comprendiendo un fármaco inhibidor de la DPP4 y de la pioglitazona, procedimientos de preparación y utilización | |
| EA201492040A1 (ru) | Бициклически замещённые урацилы и их применение | |
| BR112012024312A2 (pt) | anticorpos biespecíficos | |
| BR112014018959A8 (pt) | Compostos, composições farmacêuticas, utilizações de um composto e métodos para o tratamento do câncer | |
| EA201591195A1 (ru) | Новые хинолоновые производные | |
| EA201390381A1 (ru) | Триазиноксадиазолы | |
| CO6771439A2 (es) | Inhibidores de benzodioxano de la producción de leucotrieno | |
| DOP2015000069A (es) | Piridinonas bicíclicas novedosas | |
| EA201500298A1 (ru) | Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы | |
| BR112015010136A2 (pt) | derivados de oxazolidin-2-ona-pirimidina | |
| EA201200616A1 (ru) | Производные 2-оксо-1-пирролидинилимидазотиадиазола | |
| ECSP11010992A (es) | Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales | |
| EA201391797A1 (ru) | 3-спироциклические пиперидиновые производные в качестве агонистов грелиновых рецепторов | |
| CY1118514T1 (el) | Μεθοδος για την παρασκευη πεμετρεξιδης και αλατος λυσινης αυτης |